SCHEMBL20313490

SCHEMBL20313490

C=C(CO)C(=O)OCCOc1cc(OCCOC(=O)C(=C)CO)cc(-c2ccc(CCCCC)cc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ USP2 O75604 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ CASP1 P29466 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ SLCO1B3 Q9NPD5 1/20 0.45
▸ SLCO1B1 Q9Y6L6 1/20 0.45
▸ RARB P10826 10/20 0.44
▸ RARA P10276 2/20 0.43
▸ MAPT P10636 1/20 0.43
▸ MTOR P42345 1/20 0.43
▸ THRB P10828 2/20 0.41
▸ RARG P13631 1/20 0.41
▸ PLA2G4A P47712 1/20 0.40
▸ THRA P10827 1/20 0.40
▸ CNR1 P21554 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19855559 0.99 MEN1 (0.44) MEN1ALDH1A1KMT2AUSP2LMNA
SCHEMBL20313502 0.99 MEN1 (0.47) MEN1ALDH1A1KMT2AUSP2LMNA
SCHEMBL20313547 0.98 MEN1 (0.49) MEN1ALDH1A1KMT2AUSP2LMNA
SCHEMBL20313542 0.95 MEN1 (0.51) MEN1ALDH1A1KMT2AUSP2LMNA
SCHEMBL20313604 0.94 MEN1 (0.44) MEN1ALDH1A1KMT2AUSP2LMNA
SCHEMBL19855530 0.94 MEN1 (0.43) MEN1ALDH1A1KMT2AUSP2LMNA
SCHEMBL19855564 0.94 MEN1 (0.46) MEN1ALDH1A1KMT2AUSP2LMNA
SCHEMBL19855563 0.93 SMPD1 (0.44) MEN1ALDH1A1KMT2AUSP2LMNA
SCHEMBL19721837 0.92 MEN1 (0.54) MEN1ALDH1A1KMT2AUSP2LMNA
SCHEMBL20313507 0.92 LMNA (0.54) MEN1ALDH1A1KMT2AUSP2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214615-A1 LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT JNC CORPORATION (JP) 2021-07-15 — — US disclosed
EP-3351525-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT JNC Corporation (JP) 2018-07-25 — — EP disclosed
US-20180179443-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-06-28 — — US disclosed
US-20180179443-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-06-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180179443-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE C1S, CCND1, C5 MEN1 980/4885ALDH1A1 2615/4885KMT2A 4178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback